Beneficial Impact of a Clinical Care Pathway in Patients with Testicular Cancer Undergoing Retroperitoneal Lymph Node Dissection
- 1 July 2002
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 168 (1) , 87-92
- https://doi.org/10.1016/s0022-5347(05)64837-9
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Influence of Hospital Procedure Volume on Outcomes Following Surgery for Colon CancerJAMA, 2000
- Surgical and postoperative factors affecting length of hospital stay after radical prostatectomyCancer, 2000
- LAPAROSCOPIC RETROPERITONEAL LYMPH NODE DISSECTION FOR CLINICAL STAGE I NONSEMINOMATOUS TESTICULAR CARCINOMA: LONG-TERM OUTCOMEJournal of Urology, 2000
- LONG-TERM RESULTS FOLLOWING ADJUVANT CHEMOTHERAPY IN PATIENTS WITH CLINICAL STAGE I TESTICULAR NONSEMINOMATOUS MALIGNANT GERM CELL TUMORS WITH HIGH RISK FACTORSJournal of Urology, 1999
- Results of a Clinical Care Pathway for Radical Prostatectomy Patients in an Open Hospital – Multiphysician SystemEuropean Urology, 1999
- Testicular cancerCurrent Problems in Cancer, 1998
- CLINICAL STAGE I TESTIS CANCER: LONG-TERM OUTCOME OF PATIENTS ON SURVEILLANCEJournal of Urology, 1998
- Maintaining quality of care and patient satisfaction with radical prostatectomy in the era of cost containmentUrology, 1996
- Impact of a Collaborative Care Approach to Radical Cystectomy and Urinary ReconstructionJournal of Urology, 1995
- Original Articles: Testis Cancer: Complications of Post-Chemotherapy Retroperitoneal Lymph Node DissectionJournal of Urology, 1995